JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$5.47B |
| 2 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$3.17B |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$2.05B |
| 4 |
Amazon
AMZN
|
+$1.96B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.6B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$1.72B |
| 2 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$1.31B |
| 3 |
UnitedHealth
UNH
|
+$1.26B |
| 4 |
Automatic Data Processing
ADP
|
+$1.17B |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$1.08B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.28% |
| 2 | Technology | 17.17% |
| 3 | Healthcare | 10.79% |
| 4 | Financials | 9.36% |
| 5 | Consumer Discretionary | 8.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
4651
CALL
Ulta Beauty
ULTA
$23.4B
| $273K | ﹤0.01% |
500
+100
| +25% | +$51.3K |
2022 Q3
2 quarters
|
|
4652
Astronics
ATRO
$2.97B
| $272K | ﹤0.01% |
24,476
-3,065
| -11% | -$34.2K |
2017 Q4
21 quarters
|
|
4653
SOPHiA GENETICS
SOPH
$628M
| $272K | ﹤0.01% |
54,728
+23,336
| +74% | +$75.6K |
2022 Q3
2 quarters
|
|
|
ORAN
4654
DELISTED
Orange
ORAN
| $272K | ﹤0.01% |
22,786
+1,867
| +9% | +$20.6K |
2013 Q2
39 quarters
|
|
4655
Hingham Institution for Saving
HIFS
$629M
| $270K | ﹤0.01% |
1,155
-554
| -32% | -$152K |
2016 Q3
26 quarters
|
|
4656
Perella Weinberg Partners
PWP
$1.2B
| $270K | ﹤0.01% |
29,705
+7,031
| +31% | +$70.2K |
2021 Q3
6 quarters
|
|
4657
Western New England Bancorp
WNEB
$277M
| $269K | ﹤0.01% |
32,838
+32,811
| +121,522% | +$311K |
2017 Q4
21 quarters
|
|
4658
PUT
Chewy
CHWY
$7.29B
| $269K | ﹤0.01% |
7,200
-13,900
| -66% | -$575K |
2021 Q4
5 quarters
|
|
4659
Northeast Bank
NBN
$1.08B
| $269K | ﹤0.01% |
7,997
-102
| -1% | -$4.3K |
2016 Q4
25 quarters
|
|
|
TTSH
4660
DELISTED
Tile Shop Holdings
TTSH
| $269K | ﹤0.01% |
57,445
+11,379
| +25% | +$57.2K |
2021 Q2
7 quarters
|
|
|
ABCM
4661
PUT
DELISTED
Abcam PLC
ABCM
| $269K | ﹤0.01% |
+20,000
| New | +$298K |
2023 Q1
0 quarters
|
|
4662
Carter Bankshares
CARE
$706M
| $268K | ﹤0.01% |
19,121
-1,744
| -8% | -$28.1K |
2019 Q2
15 quarters
|
|
4663
Nathan's Famous
NATH
$417M
| $268K | ﹤0.01% |
+3,541
| New | +$262K |
2023 Q1
0 quarters
|
|
|
CERE
4664
CALL
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
| $266K | ﹤0.01% |
10,900
+9,900
| +990% | +$291K |
2022 Q4
1 quarter
|
|
4665
iShares Residential and Multisector Real Estate ETF
REZ
$780M
| $265K | ﹤0.01% |
3,755
+1
| +0% | +$72 |
2016 Q1
28 quarters
|
|
4666
Bionano Genomics
BNGO
$17.1M
| $265K | ﹤0.01% |
397
+103
| +35% | +$91.5K |
2021 Q2
7 quarters
|
|
4667
LendingTree
TREE
$347M
| $265K | ﹤0.01% |
9,924
+2,091
| +27% | +$68.6K |
2017 Q1
24 quarters
|
|
4668
Bolt Biotherapeutics
BOLT
$6.76M
| $263K | ﹤0.01% |
9,465
+8,470
| +851% | +$248K |
2021 Q1
8 quarters
|
|
4669
BlackRock Science and Technology Trust
BST
$1.77B
| $263K | ﹤0.01% |
8,113
+4
| +0% | +$127 |
2020 Q4
9 quarters
|
|
4670
VanEck Rare Earth/Strategic Metals ETF
REMX
$1.84B
| $262K | ﹤0.01% |
3,206
-275
| -8% | -$23.4K |
2018 Q4
17 quarters
|
|
4671
TETRA Technologies
TTI
$909M
| $262K | ﹤0.01% |
99,101
+25,764
| +35% | +$89.7K |
2016 Q4
25 quarters
|
|
4672
Franklin Municipal Green Bond ETF
FLMB
$53.7M
| $261K | ﹤0.01% |
+10,900
| New | +$259K |
2023 Q1
0 quarters
|
|
4673
Universal Logistics Holdings
ULH
$447M
| $261K | ﹤0.01% |
8,947
-2,076
| -19% | -$67.4K |
2013 Q2
39 quarters
|
|
4674
BlackRock Multi-Sector Income Trust
BIT
$641M
| $260K | ﹤0.01% |
+17,847
| New | +$264K |
2023 Q1
0 quarters
|
|
4675
Spok Holdings
SPOK
$229M
| $260K | ﹤0.01% |
25,658
+15,886
| +163% | +$145K |
2022 Q4
1 quarter
|
|
Similar funds
JP Morgan Chase's Q1 2023 Portfolio in Review
As of Q1 2023, JP Morgan Chase held 7,579 positions worth $821B, up 8.2% from $759B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q1 2023 filing shows 751 new, 3,314 increased, 2,056 reduced and 652 closed positions. Its largest new stake was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M. The largest sale was Eli Lilly, an estimated $1.72B.
By sector, the portfolio is most concentrated in Miscellaneous at 27% of assets, up from 27% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q1 2023 buy was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M.
- JP Morgan Chase added most to JPMorgan BetaBuilders Europe ETF in Q1 2023, an estimated $5.47B increase.
- JP Morgan Chase's biggest Q1 2023 reduction was Eli Lilly, cutting an estimated $1.72B.
- JP Morgan Chase fully exited IAA, Inc. Common Stock in Q1 2023, selling an estimated $155M.
- JP Morgan Chase's ten largest holdings make up 17% of its $821B portfolio in Q1 2023.
- JP Morgan Chase opened 751 new positions and closed 652 in Q1 2023.
- JP Morgan Chase's portfolio value rose 8.2% quarter-over-quarter to $821B.
Based on JP Morgan Chase's 13F filing for Q1 2023, filed 11 May 2023.